Routine Surveillance after Breast Cancer Treatment

As part of routine surveillance of patients diagnosed with breast cancer, the following is recommended according to the NCCN guidelines:

• History and physical exam:
  • 1 to  4 times per year, as clinically appropriate, for 5 years, and then annually
• Educate, monitor, and refer for lymphedema management
• Mammography every year
• In the absence of symptoms, there is no evidence to support laboratory or imaging studies for metastatic screening
• Women on tamoxifen should have annual gynecologic screening
• Women on aromatase inhibitor therapy should have monitoring of bone health and density at baseline and periodically thereafter
• Assess and encourage adherence to adjuvant endocrine therapy
• Evidence suggests that active lifestyle and achieving and maintaining an ideal body weight (20-25 BMI) may lead to optimal breast cancer outcomes

Rodrigo Arrangoiz MS, MD, FACS a surgical oncologist and is a member of Sociedad Quirúrgica S.C at the America British Cowdray Medical Center in Mexico City:

• He is an expert in the management of breast cancer.

  • If you have any questions about the screening for breast cancer please fill free to contact Dr. Arrangoiz.

Training:

• General surgery:

• Michigan State University:

• 2004 al 2010

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• Fox Chase Cancer Center (Filadelfia):

• 2010 al 2012

• Masters in Science (Clinical research for health professionals):

• Drexel University (Filadelfia):

• 2010 al 2012

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• IFHNOS / Memorial Sloan Kettering Cancer Center:

• 2014 al 2016

#Arrangoiz

#Surgeon

#Cirujano

#SurgicalOncologist

#CirujanoOncologo

#BreastSurgeon

#CirujanodeMama

#CancerSurgeon

#CirujanodeCancer

http://www.sociedadquirurigca.com